Properties |
Information |
PhytoCAT-ID |
PhytoCAT-440 |
Phytochemical name or plant extracts |
Glycyrrhizin |
PMID |
28506909 |
Literature evidence |
Triple negative breast cancer(TNBC) has generated growing interests due to its aggressive biologic behavior and absence of targeted therapy approach. |
IUPAC name |
(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid |
Phytochemicals’ class or type of plant extracts |
Triterpenoid saponin |
Source of phytochemicals or plant Extracts |
Glycyrrhiza glabra |
|
Geographical availability |
Afghanistan, Albania, Bulgaria, Central European Rus, China North-Central, Cyprus, East Aegean Is., East European Russia, Greece, Iran, Iraq, Italy, Kazakhstan, Kirgizstan, Krym, Lebanon-Syria, Mongolia, North Caucasus, Pakistan, Palestine, Romania, Sardegna, Saudi Arabia, Sicilia, South European Russi, Tadzhikistan, Transcaucasus, Turkey, Turkmenistan, Ukraine, Uzbekistan, West Siberia, Xinjiang, Yugoslavia |
Plant parts |
Root |
Other cancers |
Breast cancer, Cervical cancer |
Target gene or protein |
NA |
Gene or Protein evidence |
NA |
Target pathways |
AKT pathway
ERK and JNK of MAPK pathway |
IC50 |
NA |
Potency |
Collectively, our results demonstrate that GA, instead of GL, is a better candidate for TNBC treatment because of its anti-cancer effect and sensitization of topoisomerase IIα inhibitor. |
Cell line/ mice model |
MDA-MB-231, HeLa, MCF-7 |
Additional information |
However, GL showed protection and detoxication by decreasing reactive oxygen species generation, maintaining GSH and differentially modulating apoptosis, AKT pathway, ERK and JNK of MAPK pathway. |
PubChem ID |
14982 |
Additional PMIDs |
18849542 24696551 28506909 20857541 |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:496941-1 |
Safety |
NA |